DCA Edgefield is a medicare approved dialysis facility center in Edgefield, South Carolina and it has 15 dialysis stations. It is located in Edgefield county at 306 Main Street, Edgefield, SC, 29824. You can reach out to the office of DCA Edgefield at (803) 637-3225. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. DCA Edgefield has the following ownership type - Profit. It was first certified by medicare in March, 2006. The medicare id for this facility is 422602 and it accepts patients under medicare ESRD program.
| Name | DCA Edgefield |
|---|---|
| Location | 306 Main Street, Edgefield, South Carolina |
| No. of Dialysis Stations | 15 |
| Medicare ID | 422602 |
| Managed By | Us Renal Care, Inc. |
| Ownership Type | Profit |
| Late Shifts | No |
| 306 Main Street, Edgefield, South Carolina, 29824 | |
| (803) 637-3225 | |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
| NPI Number | 1013966480 |
| Organization Name | U S Renal Care Edgefield Dialysis |
| Doing Business As | Dca Of Edgefield Llc |
| Address | 306 Main Street Edgefield, South Carolina, 29824 |
| Phone Number | (803) 637-3225 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 28 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 7 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 47 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 504 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at DCA Edgefield with elevated calcium levels.
| Patients with hypercalcemia | 47 |
| Hypercalcemia patient months | 504 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
| Patients with Serumphosphor | 48 |
| Patients with Serumphosphor less than 3.5 mg/dL | 16 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 19 |
| Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 37 |
| Patient months included in arterial venous fistula and catheter summaries | 404 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 68 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 42 |
| Hospitalization Rate in facility | 78 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 188.7 |
| Hospitalization Rate: Lower Confidence Limit | 34.3 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at DCA Edgefield were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 23.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 48.3 |
| Readmission Rate: Lower Confidence Limit | 8.2 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at DCA Edgefield get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.4 (As Expected) |
| SIR: Upper Confidence Limit | 3.81 |
| SIR: Lower Confidence Limit | .36 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether DCA Edgefield's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 38 |
| Transfusion Rate in facility | 36 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 104.6 |
| Transfusion Rate: Lower Confidence Limit | 14.2 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at DCA Edgefield lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 192 |
| Mortality Rate in facility | 10.2 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 16.3 |
| Mortality Rate: Lower Confidence Limit | 5.9 |
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago
News Archive
Researchers in Israel have conducted a study showing that the use of Pfizer-BioNTech's coronavirus disease 2019 (COVID-19) vaccine appears to be safe and effective among patients with cancer.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare.
The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston scientist.
› Verified 1 days ago